Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
If cleared, Merck's drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.
Read more at:
Merck says experimental drug molnupiravir cuts worst effects of COVID-19 | CBC News
Showing posts with label Pill. Show all posts
Showing posts with label Pill. Show all posts
Tuesday, October 5, 2021
Friday, October 1, 2021
USA: Covid-19 medicine: Merck says antiviral COVID-19 pill halves death and hospitalizations
US pharmaceutical giant Merck announced on Friday the results of an internal study of its antiviral COVID-19 treatment pills. It said the results showed hospitalizations and deaths were reduced by half when taken by people recently infected with COVID-19, although academic peer review is not yet completed.
The company will soon ask health officials in the US and around the world to authorize the use of the drug, called molnupiravir. It would be the first antiviral pill to treat COVID-19 effectively, a potential turning point in the pandemic.
Read more at: Merck says antiviral COVID-19 pill halves death and hospitalizations | News | DW | 01.10.2021
The company will soon ask health officials in the US and around the world to authorize the use of the drug, called molnupiravir. It would be the first antiviral pill to treat COVID-19 effectively, a potential turning point in the pandemic.
Read more at: Merck says antiviral COVID-19 pill halves death and hospitalizations | News | DW | 01.10.2021
Subscribe to:
Posts (Atom)